James W. Mccollum - Nov 7, 2025 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Director
Signature
/s/ Daniel R. Chevallard, as Attorney-in-Fact
Stock symbol
LENZ
Transactions as of
Nov 7, 2025
Transactions value $
$239,278
Form type
4
Date filed
11/10/2025, 04:13 PM
Previous filing
Jun 11, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCCOLLUM JAMES W Director C/O LENZ THERAPEUTICS, INC., 201 LOMAS SANTA FE, SUITE 300, SOLANA BEACH /s/ Daniel R. Chevallard, as Attorney-in-Fact 2025-11-10 0001200889

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LENZ Common Stock Purchase $239K +10.5K $22.79 10.5K Nov 7, 2025 Direct F1
holding LENZ Common Stock 621K Nov 7, 2025 By trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 10,500 shares purchased in the price range of $22.68 to $22.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 95,034 shares transferred by the Reporting Person to the McCollum Living Trust on June 6, 2024.